Frank A. Scappaticci

3.7k citations
38 papers · 2.8k indexed · 1 hit paper · h-index 22
Topics
Colorectal Cancer Treatments and Studies (15 papers)Cancer Treatment and Pharmacology (11 papers)Cancer Genomics and Diagnostics (6 papers)

In The Last Decade

Frank A. Scappaticci

38 papers receiving 2.8k citations

Hit Papers

Arterial Thromboembolic Events in Patients with Metastati...20072026201320192007200400600

Peers

Frank A. Scappaticci
Comparison fields: 5 of 91
  • Oncology 1.4k
  • Molecular Biology 1.2k
  • Pulmonary and Respiratory Medicine 856
  • Cancer Research 470
  • Hepatology 336
Replace James D. Reimann with:
James D. Reimann United States
Wei‐Xiang Qi China
Ignacio Gil‐Bazo Spain
Russell F. DeVore United States
Peter Langmuir United States
C.J. van Groeningen Netherlands
Carl Zuelke Germany
Lina Tang China
Ali Amirkhosravi United States
Michael McCleod United States
Frank A. Scappaticci relative to James D. Reimann United States James D. Reimann's profile →
Citations per field
00.5×7.3×
James D. Reimann · 1×
Citations per year

Countries citing papers authored by Frank A. Scappaticci

Since Specialization
Citations

This map shows the geographic impact of Frank A. Scappaticci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank A. Scappaticci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank A. Scappaticci more than expected).

Fields of papers citing papers by Frank A. Scappaticci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank A. Scappaticci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank A. Scappaticci. The network helps show where Frank A. Scappaticci may publish in the future.

Co-authorship network of co-authors of Frank A. Scappaticci

This figure shows the co-authorship network connecting the top 25 collaborators of Frank A. Scappaticci. A scholar is included among the top collaborators of Frank A. Scappaticci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank A. Scappaticci. Frank A. Scappaticci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 66
2 39
3 87
4 24
5 54
6 34
7
Arterial Thromboembolic Events in Patients with Metastatic Carcinoma Treated with Chemotherapy and Bevacizumabbreakdown →
725
8 57
9 102
10 396
11 138
12 2
13 11
14 17
15 27
16 17
17 92
18 8
19 19
20 10

About Frank A. Scappaticci

Frank A. Scappaticci is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 38 papers that have together received 2.8k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (15 papers), Cancer Treatment and Pharmacology (11 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Oncology (1.4k citations), Hepatology (336 citations) and Internal Medicine (140 citations). Frank A. Scappaticci has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Fairooz F. Kabbinavar, Scott N. Holden, Eric Holmgren, Jamey Skillings, Emily K. Bergsland, Kathy D. Miller, H. Hurwitz, Hans Peter Gerber, Jia Wang and Jenny Ngai. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026